The Meat Industry’s “Cultural” Revolution

By Madiha Saeed, MD & Erik Goldman

A Korean Bi Bim Bap style dish prepared with Gaia Foods’ tissue-cultured beef. Based in Singapore, Gaia Foods is one of dozens of companies worldwide now racing to market with cultured chicken, beef, lamb, pork and fish products grown entirely from cell samples, without the need to raise or slaughter animals. (Image: Gaia Foods)

The meat industry is about to undergo a “cultural” revolution…..a tissue culture revolution, to be precise.

The soaring global demand for meat has opened doors to alternative ways of producing consumable animal tissue, ushering in the first major challenge to industrial-scale animal agriculture in history. Numerous companies worldwide, some backed by major investors, are now applying tissue culture techniques to produce beef, chicken, and even some types of seafood, without raising or killing animals.

Though this emerging industry is still in an early phase of development, it took center stage in the US last November, when the Food and Drug Administration declared tissue cultured chicken safe for human consumption.

[ ...Read More ]

Featured Articles

Probiotics in Clinical Practice: Simple Stories, Complex Realities

Written by Erik Goldman

Twenty years ago, “the microbiome” was an obscure little domain within microbiology, and the term probiotic, to the extent anyone had heard it at all, usually meant eating yogurt and fermented vegetables in the vague hope it would promote longevity.  Today, the microbiome is one of the most widely known and fastest growing healthcare phenomena […]

[ ...Read More ]

Teenage Diabetes on the Rise

Written by August West, Contributing Writer

If current trends continue, the total number of American teenagers living with diabetes will rise by at least 12% by the year 2060, a surge driven largely by a staggering 70% increase in Type 2 disease. That’s the troubling message from Thaddäus Tönnies and colleagues at the Leibniz Center for Diabetes Research at the Heinrich […]

[ ...Read More ]

HPC Video

Webinar: Understanding the Impact of California's AB 2098 on Practitioners and the Natural Product Industry

Written by Erik Goldman

Last summer, the California legislature passed a new law (AB 2098) deputizing the state’s medical board to take disciplinary action—including revocation of licenses—against MDs and DOs who spread Covid-related “disinformation” or “misinformation.”

While clearly intended to target doctors who question or criticize federal and state vaccine policies, AB 2098 is based on a broad definition of mis- and disinformation that could be interpreted to include any modality that falls outside “scientific consensus” or current “standards of care.”

Many view AB 2098 as a gag law intended to squelch dialog about medical alternatives. Consequently, it has implications far beyond California, and far beyond Covid. The bill had unconditional support from the AMA, and other states are considering similar laws.

At the end of January, advocates of medical free speech won a major victory when US District Judge William Shubb issued a preliminary injunction blocking the California Attorney General from enforcing AB 2098.

While that’s an important win, the fight over AB 2098 is just beginning.

Join us for an in-depth live interview with Rick Jaffe, Esq, the attorney whose efforts on the landmark Hoang v. Bonta case succeeded in winning the injunction that stopped the implementation of AB 2098…at least temporarily.

We’ll cover:
• The background of AB 2098 and the forces behind it
• How the law defines “misinformation” and “disinformation”
• How many other states are considering similar bills
• The potential risks to holistic, functional, and naturopathic practitioners
• The significance of the preliminary injunction, and what happens next
• Potential impact on practitioners who recommend or sell supplements
• Implications for the natural products industry

Richard Jaffe, Esq, is a health care litigator, focusing on cutting-edge medical/legal issues. He holds a JD from Columbia Law School where he was a member of the Columbia Law Review and a Stone Scholar, and a BA with honors from the Hebrew University of Jerusalem where he received a prize for academic excellence in the History and Philosophy of Science. He is admitted to practice law in California, Texas, and New York. His main focus is on litigation, criminal and administrative investigations involving significant health care issues throughout the country. His book, Galileo’s Lawyer tells the stories of medical mavericks who faced off against the government, and gives an insider’s view on some of his high-profile and controversial medical cases.

[ ...Read More ]